Researchers from the University of Colorado Boulder, in collaboration with Stanford Medicine and Baylor University, have identified a group of metabolites in python blood that may play a role in appetite suppression and metabolic regulation.
The findings, published on March 19, 2026, in the journal Nature Metabolism, suggest potential pathways for developing new weight loss therapies that avoid common side effects such as nausea and muscle loss of GLP-1 drugs.
The research was led by Leslie Leinwand who studies python metabolism extensively since last 20 years.
The study focused on understanding how pythons manage extreme feeding patterns, consuming large meals and then fasting for extended periods without adverse metabolic effects.
Pythons exhibit a unique metabolic cycle:
They consume large prey in a single meal
They can go weeks to months without eating afterward
Despite this, they maintain muscle mass and overall metabolic health
After feeding, their bodies undergo rapid physiological changes, including:
Significant increase in metabolic rate
Enhanced digestion efficiency
Activation of nutrient-processing pathways
One notable adaptation is that a python’s heart can enlarge by up to 25% after feeding, allowing it to support the sudden metabolic demand. This enlargement is temporary and reverses after digestion is complete, indicating a controlled and adaptive physiological response.
The study identified a specific metabolite, called para-tyramine-O-sulfate (pTOS) in python blood that appear to signal satiety (feeling of fullness), regulate energy usage and influence metabolic pathways linked to fat and muscle balance.
These compounds may interact with biological systems involved in appetite regulation, potentially affecting hormones and neural signals that control hunger.
Current weight loss medications with GLP-1 drugs, including those targeting appetite suppression, may be associated with side effects such as:
Nausea
Gastrointestinal discomfort
Loss of lean muscle mass
The metabolites identified in python blood could offer an alternative approach by:
Promoting satiety without severe side effects
Supporting muscle preservation
Maintaining metabolic balance during reduced food intake
Researchers suggest that studying these naturally occurring compounds may help design therapies that mimic python metabolism in a controlled manner.
The research also points to possible interactions between python metabolism and gut-related processes.
Pythons demonstrate several adaptations that enable extended fasting:
Reduced baseline metabolic rate between meals
Efficient fat utilization for energy
Preservation of muscle tissue
Reversible organ enlargement (e.g., heart and digestive organs)
These features collectively allow them to avoid the negative effects typically associated with prolonged fasting in humans.
The discovery of appetite-regulating metabolites in python blood highlights a novel area of metabolic research. By studying these unique biological mechanisms, scientists aim to develop safer and more effective approaches to weight management that preserve muscle mass and minimize adverse effects.
References
Marshall, Lisa. 2026. “Python Blood Could Hold the Secret to Healthy Weight Loss.” University of Colorado Boulder, March 19, 2026. https://www.colorado.edu/today/2026/03/19/python-blood-could-hold-secret-healthy-weight-loss
Xiao, Shuke, Mengjie Wang, Thomas G. Martin, et al. 2026. “Python Metabolomics Uncovers a Conserved Postprandial Metabolite and Gut–Brain Feeding Pathway.” Nature Metabolism. https://doi.org/10.1038/s42255-026-01485-0.
